Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

1. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation Full Text available with Trip Pro

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation - Canadian Journal of Cardiology Go search Please enter a term before submitting your search. , P1847-1948, December 01, 2020 Powered By Mendeley Share on The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm (...) Society Comprehensive Guidelines for the Management of Atrial Fibrillation Jason G. Andrade Correspondence Corresponding author: Dr Jason G. Andrade, 2775 Laurel St, Vancouver, British Columbia V5Z 1M9, Canada. Tel.: +1-604-875-5069; fax: +1-604-875-5874. Affiliations University of British Columbia, Vancouver, British Columbia, Canada Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada Martin Aguilar Affiliations Institut de Cardiologie de Montréal, Université de

2021 Canadian Cardiovascular Society

2. Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation

Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health National Library (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Am Coll Cardiol Actions . 2021 Jan 5;77(1):57-67. doi: 10.1016/j.jacc.2020.10.049. Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation , , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang

2021 EvidenceUpdates

3. Managing Atrial Fibrillation in the ED

Managing Atrial Fibrillation in the ED September 2020 — Emergency Medicine Journal Club Archives Clinical Tools Residents / / / / / / September 2020 / / / / / / Managing Atrial Fibrillation in the Emergency Department. This month one of our residents presented a perfect scenario for a JC topic namely, disparate advice provided by different attendings regarding selection of the most appropriate agent of choice when managing a patient presenting with atrial fibrillation and RVR. Unfortunately, I

2021 Emergency Medicine Journal Club

4. Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)

Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal) Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal) T echnology appraisal guidance Published: 17 February 2021 www.nice.org.uk/guidance/ta675 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Contents Contents Advice 3 Information 3 Vernakalant (...) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal) (TA675) © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 3Advice Advice NICE is unable to make a recommendation about the use in the NHS of vernakalant for the rapid conversion of recent onset atrial fibrillation (7 days or less) to sinus rhythm in adults who have not had surgery. This is because Correvio Ltd did

2021 National Institute for Health and Clinical Excellence - Technology Appraisals

5. Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial Full Text available with Trip Pro

Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Open Actions . 2020 Dec 1;3(12):e2025473. doi: 10.1001/jamanetworkopen.2020.25473. Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiology, Southlake Regional Health Centre, University of Toronto, Newmarket, Ontario, Canada. 2 Department of Cardiology, Santa Maria dei Battuti Hospital, Conegliano, Italy. 3

2021 EvidenceUpdates

6. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation

Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable (...) )31287-X. doi: 10.1016/j.amjcard.2020.12.001. Online ahead of print. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation , , , , , , , Affiliations Expand Affiliations 1 Department of Cardiology, ShunDe Hospital of Guangzhou University of Chinese Medicine, Foshan, Guangdong, People's Republic of China. 2 Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

2021 EvidenceUpdates

7. 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures Full Text available with Trip Pro

2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures | Circulation (...) : Cardiovascular Quality and Outcomes Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task

2020 American Heart Association

8. Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study Full Text available with Trip Pro

Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) . 2020 Nov 2. doi: 10.1111/dom.14243. Online ahead of print. Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study , , , , , , , , , Affiliations Expand Affiliations 1 Departments of Family Medicine and Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. 2 Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan

2020 EvidenceUpdates

9. Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation

Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) )31202-9. doi: 10.1016/j.amjcard.2020.10.064. Online ahead of print. Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation , , , , , Affiliations Expand Affiliations 1 University of Toronto, Toronto, Canada. 2 Department of Medicine, University of Toronto, Toronto, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, Canada. Electronic address: andrew.ha@uhn.ca. 3 Department of Medicine

2020 EvidenceUpdates

10. 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter PERFORMANCE MEASURES 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures Developed in Collaboration With the Heart Rhythm Society Writing Committee Members Paul A. Heidenreich, MD, MS (...) .. - PREAMBLE - 1.DECISION TO UPDATE THE ATRIAL FIBRILLATION MEASURE ON ANTICOAGULATION .. - 1.1. Background - 2.ACC/AHA UPDATEDATRIAL FIBRILLATION MEASURE ON ANTICOAGULATION AND UPDATED PERFORMANCE MEASURES ... - 2.1. Discussion of Changes to the Atrial Fibrillation Measure on Anticoagulation - REFERENCES ... - APPENDIX A Updated Atrial Fibrillation Measures .. - Short Title: PM-1: CHA 2 DS 2 -VASc Risk Score Documented Prior to Discharge - Short Title: PM-2: Anticoagulation Prescribed Prior to Discharge

2020 Heart Rhythm Society

11. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery Full Text available with Trip Pro

Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) . Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery , , , , , , , , Collaborators, Affiliations Expand Collaborators ART Investigators

2020 EvidenceUpdates

12. Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials

Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) -2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials , , , Affiliations Expand Affiliations 1 Department of Internal Medicine, East Carolina University, Greenville, North Carolina, USA. 2 Department of Family Medicine, East Carolina University, Greenville, North Carolina, USA. PMID: 33001548 DOI: Item in Clipboard Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials Victor Okunrintemi et al. Diabetes Obes

2020 EvidenceUpdates

13. KardiaMobile for the ambulatory detection of atrial fibrillation

KardiaMobile for the ambulatory detection of atrial fibrillation KardiaMobile for the ambulatory detection of atrial fibrillation Medtech innovation briefing Published: 29 October 2020 www.nice.org.uk/guidance/mib232 pathways This advice replaces MIB35. Summary Summary • The technology technology described in this briefing is the KardiaMobile heart monitor and Kardia app (AliveCor) used for identifying atrial fibrillation (AF). • The innovative aspect innovative aspect is its simple mode (...) it to a healthcare professional for interpretation. KardiaMobile has 2 electrodes on the top surface; 2 fingers from the left hand are placed onto 1 electrode and 2 fingers from the right hand are placed onto the other electrode. The user must keep their arms still and must keep touching the electrodes for at least 30 seconds for a complete reading to be taken. The company recommends that recordings are taken daily, or whenever atrial fibrillation (AF) symptoms are experienced. A user may also be given specific

2020 National Institute for Health and Clinical Excellence - Advice

14. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. (Abstract)

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk.In this international, investigator-initiated, parallel-group, open, blinded-outcome-assessment trial, we randomly assigned patients who had early atrial fibrillation (diagnosed ≤1 year before enrollment (...) ) and cardiovascular conditions to receive either early rhythm control or usual care. Early rhythm control included treatment with antiarrhythmic drugs or atrial fibrillation ablation after randomization. Usual care limited rhythm control to the management of atrial fibrillation-related symptoms. The first primary outcome was a composite of death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome; the second primary outcome was the number of nights

2020 NEJM

15. Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies Full Text available with Trip Pro

Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies | Stroke and Vascular Neurology Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies Article Text Brief report Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis

2020 Stroke and vascular neurology

16. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. Full Text available with Trip Pro

Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. To investigate whether opportunistic screening in primary care increases the detection of atrial fibrillation compared with usual care.Cluster randomised controlled trial.47 intention-to-screen and 49 usual care primary care practices in the Netherlands, not blinded for allocation; the study was carried out from September 2015 to August 2018.In each practice (...) , a fixed sample of 200 eligible patients, aged 65 or older, with no known history of atrial fibrillation in the electronic medical record system, were randomly selected. In the intention-to-screen group, 9218 patients eligible for screening were included, 55.0% women, mean age 75.2 years. In the usual care group, 9526 patients were eligible for screening, 54.3% women, mean age 75.0 years.Opportunistic screening (that is, screening in patients visiting their general practice) consisted of three index

2020 BMJ

17. Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials Full Text available with Trip Pro

Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials Frontiers | Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials | Cardiovascular Medicine 0.05 for each and all 95% confidence interval (CI (...) Mount Sinai Hospital, United States The editor and reviewers' affiliations are the latest provided on their Loop research profiles and may not reflect their situation at the time of review. TABLE OF CONTENTS total views SHARE ON Systematic Review ARTICLE Front. Cardiovasc. Med., 10 September 2020 | Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled

2020 Frontiers in cardiovascular medicine

18. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. (Abstract)

Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack. Outcomes of postoperative atrial fibrillation (AF) after noncardiac surgery are not well defined.To determine the association of new-onset postoperative AF vs no AF after noncardiac surgery with risk of nonfatal and fatal outcomes.Retrospective cohort study in Olmsted County, Minnesota, involving 550 patients who had their first-ever documented AF within 30 days after

2020 JAMA

19. Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation: Task Force for the Development of Quality Indicators in Atrial Fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation: Task Force for the Development of Quality Indicators in Atrial Fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) Quality indicators for the care and outcomes of adults with atrial fibrillation Task Force for the development of quality indicators in atrial fibrillation of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC (...) , as well as PROMs. Conclusion This document de?nes six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and manage- ment of AF. It is anticipated that implementation of these QIs will improve the quality of AF care. Keywords Atrial ?brillation • Quality indicators • Outcome measures Abbreviations AF atrial fibrillation EORP EURObservational

2020 Heart Rhythm Society

20. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke Diagnostics guidance Published: 2 September 2020 www.nice.org.uk/guidance/dg41 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration (...) atrial fibrillation after cryptogenic stroke (DG41) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 50Contents Contents 1 Recommendations 4 2 The diagnostic tests 6 Clinical need and practice 6 The interventions 6 The comparator 11 3 Evidence 12 Clinical effectiveness 12 Cost effectiveness 26 4 Committee discussion 35 Clinical need 35 Clinical effectiveness 36 Cost effectiveness 38 Research considerations 45 5

2020 National Institute for Health and Clinical Excellence - Diagnostics Guidance